Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Norman

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
American Heart Journal|July 11, 2006
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) studyAllan S Jaffe, Harlan M Krumholz, Diane J Catellier, et al.
BMJ Open Quality|July 7, 2026
Improving opioid substitution therapy in the acute hospital setting: implementation of a best practice guidelineMichael Trent Herdman, Brihitejas Patel, Poppy Pierce, et al.
JAMA|June 19, 2003
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized TrialLisa F Berkman, James Blumenthal, Matthew Burg, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
American Heart Journal|July 11, 2006
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) studyAllan S Jaffe, Harlan M Krumholz, Diane J Catellier, et al.
BMJ Open Quality|July 7, 2026
Improving opioid substitution therapy in the acute hospital setting: implementation of a best practice guidelineMichael Trent Herdman, Brihitejas Patel, Poppy Pierce, et al.
JAMA|June 19, 2003
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized TrialLisa F Berkman, James Blumenthal, Matthew Burg, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Pageof 6